Core Standards

The ICH Q1 through Q7 guidelines focus on various aspects of pharmaceutical quality and safety, including stability testing, analytical method validation, impurity control, and good manufacturing practices. Q1 emphasizes stability studies, while Q2 covers the reliability of analytical methods. Q3 addresses impurity management, and Q4 promotes harmonization of pharmacopoeial standards. Q5 focuses on biotechnological products, Q6 outlines specifications for drug quality, and Q7 details GMP for active pharmaceutical ingredients. Additionally, Q13 discusses continuous manufacturing practices, and Q14 provides guidance on analytical method development and validation, ensuring a consistent approach to product quality across the industry.